Funder: Pulmonary Fibrosis Foundation

Due Dates: Rolling (Consortium membership and research proposals)

Funding Amounts: No fixed award amount; support varies by project and consortium participation.

Summary: Consortium advancing biomarker research and personalized treatment strategies for pulmonary fibrosis through collaborative industry-academic partnerships.

Key Information: Open to new members from academia, industry, and non-profits; focus on translational biomarker research in IPF.